Laevogo Pflaumenaroma (Lactulose, Liquid)

Lactulose reaches the colon unchanged, where intestinal bacteria break it down into short‑chain fatty acids. These acids increase the osmotic pressure in the lumen, drawing water into the bowel to soften stools. The resulting acidic environment also converts ammonia to ammonium, trapping it for excretion and thereby reducing systemic ammonia concentrations.

The dose of lactulose is individualized. A prescribing healthcare professional determines the amount, frequency, and duration based on the patient’s age, weight, severity of constipation or hepatic encephalopathy, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for lactulose in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their obstetrician or healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any temperature requirements), and assists with import documentation.

Lactulose is an osmotic laxative that works by increasing colonic water content and acidifying the lumen, whereas agents such as polyethylene glycol (PEG) also draw water but do not significantly lower colonic pH. Lactulose has the added benefit of reducing ammonia in hepatic encephalopathy, a property not shared by most other laxatives.

Store the liquid oral solution at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture, direct sunlight, and extreme temperature fluctuations. Do not freeze the product. If the solution appears discolored or contains particles, discard it and obtain a new supply.

The product is taken orally. The prescribed volume is measured with a calibrated dosing device (e.g., oral syringe or measuring cup) and ingested directly or mixed with a small amount of water or juice if needed. Dosing frequency and timing are set by the prescriber, and the medication should be taken with or without food as directed.

Serious adverse events, though uncommon, include severe electrolyte disturbances (such as hyponatremia or hypokalemia), marked dehydration, and allergic reactions that may present as rash, swelling, or difficulty breathing. Patients experiencing persistent watery diarrhea, faintness, or signs of an allergic response should seek medical attention promptly.

Lactulose should be avoided in individuals with known or suspected mechanical intestinal obstruction, severe inflammatory bowel disease, or acute abdominal conditions. Patients with uncontrolled diabetes, significant renal impairment, or those who have experienced severe allergic reactions to lactulose previously should also be evaluated carefully before use.